Oncology Institute Inc (TOI) Stock: What Does the Chart Say Monday?

Oncology Institute Inc (TOI) stock is lower by 7.89% over the past week and gets a Bearish rating from InvestorsObserver Sentiment Indicator.

Oncology Institute Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on TOI!

See Full TOI Report

What is Stock Sentiment?

In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company. Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish. InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion. For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.

What's Happening With TOI Stock Today?

Oncology Institute Inc (TOI) stock is flat 0% while the S&P 500 has fallen -0.5% as of 12:50 PM on Monday, Oct 2. TOI is flat $0.00 from the previous closing price of $1.40 on volume of 319,907 shares. Over the past year the S&P 500 is up 15.98% while TOI has fallen -70.65%. TOI lost -$0.67 per share in the over the last 12 months.

More About Oncology Institute Inc

The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financia, counseling, clinical trials, comprehensive lab testing, and end-of-life counseling.The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. Click Here to get the full Stock Report for Oncology Institute Inc stock.